Lilly’s Mounjaro Shows Strong Sales And Data As Firm Eyes Obesity Market

 
• By Alaric DeArment

Excluding COVID-19 antibodies, the company said revenues for the quarter increased by 10% while volume increased by 18%, and sales of Mounjaro came in stronger than analysts anticipated.

Lilly announced its first quarter 2023 earnings • Source: Shutterstock

More from Earnings

More from Business